Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000948072 | SCV001094267 | likely benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002434310 | SCV002753303 | likely benign | Inborn genetic diseases | 2022-05-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001272190 | SCV001453920 | likely benign | Dyskeratosis congenita | 2019-12-09 | no assertion criteria provided | clinical testing | |
Genetic Services Laboratory, |
RCV003151229 | SCV003839996 | likely benign | not specified | 2022-02-21 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004533630 | SCV004752760 | likely benign | RTEL1-related disorder | 2019-07-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |